Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
Giraldo, Nicolas A, Becht, Etienne, Pagès, Franck, Skliris, Georgios, Verkarre, Virginie, Vano, Yann, Mejean, Arnaud, Saint-Aubert, Nicolas, Lacroix, Laetitia, Natario, Ivo, Lupo, Audrey, Alifano, Marco, Damotte, Diane, Cazes, Aurelie, Triebel, Frederic, Freeman, Gordon J, Dieu-Nosjean, Marie-Caroline, Oudard, Stephane, Fridman, Wolf H, Sautès-Fridman, Catherine
Published in Clinical cancer research (01.07.2015)
Published in Clinical cancer research (01.07.2015)
Get full text
Journal Article
Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma
Atkinson, Victoria, Khattak, Adnan, Haydon, Andrew, Eastgate, Melissa, Roy, Amitesh, Prithviraj, Prashanth, Mueller, Christian, Brignone, Chrystelle, Triebel, Frederic
Published in Journal for immunotherapy of cancer (01.11.2020)
Published in Journal for immunotherapy of cancer (01.11.2020)
Get full text
Journal Article
Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients--Report of a Phase I/IIa Clinical Trial
Legat, Amandine, Maby-El Hajjami, Hélène, Baumgaertner, Petra, Cagnon, Laurène, Abed Maillard, Samia, Geldhof, Christine, Iancu, Emanuela M, Lebon, Luc, Guillaume, Philippe, Dojcinovic, Danijel, Michielin, Olivier, Romano, Emanuela, Berthod, Grégoire, Rimoldi, Donata, Triebel, Frédéric, Luescher, Immanuel, Rufer, Nathalie, Speiser, Daniel E
Published in Clinical cancer research (15.03.2016)
Published in Clinical cancer research (15.03.2016)
Get full text
Journal Article
MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial
Romano, Emanuela, Michielin, Olivier, Voelter, Verena, Laurent, Julien, Bichat, Hélène, Stravodimou, Athina, Romero, Pedro, Speiser, Daniel E, Triebel, Frédéric, Leyvraz, Serge, Harari, Alexandre
Published in Journal of translational medicine (12.04.2014)
Published in Journal of translational medicine (12.04.2014)
Get full text
Journal Article
Immunophenotyping of Peripheral Blood Mononuclear Cells in Septic Shock Patients With High-Dimensional Flow Cytometry Analysis Reveals Two Subgroups With Differential Responses to Immunostimulant Drugs
Wang, Ya, Gloss, Brian, Tang, Benjamin, Dervish, Suat, Santner-Nanan, Brigitte, Whitehead, Christina, Masters, Kristy, Skarratt, Kristen, Teoh, Sally, Schibeci, Stephen, Fewings, Nicole, Brignone, Chrystelle, Triebel, Frederic, Booth, David, McLean, Anthony, Nalos, Marek
Published in Frontiers in immunology (22.03.2021)
Published in Frontiers in immunology (22.03.2021)
Get full text
Journal Article
Soluble human LAG-3 molecule amplifies the In vitro generation of type 1 tumor-specific immunity
CASATI, Chiara, CAMISASCHI, Chiara, BINI, Francesca, ARIENTI, Flavio, RIVOLTINI, Licia, TRIEBEL, Frédéric, PARMIANI, Giorgio, CASTELLI, Chiara
Published in Cancer research (Chicago, Ill.) (15.04.2006)
Published in Cancer research (Chicago, Ill.) (15.04.2006)
Get full text
Journal Article
595 Biomarker results from the 1st line non-small cell lung cancer cohort of TACTI-002: pharmacodynamic effects of combining eftilagimod alpha (soluble LAG-3) and pembrolizumab
Forster, Martin, Felip, Enriqueta, Majem, Margarita, Doger, Bernard, Clay, Tim, Carcereny, Enric, Bondarenko, Igor, Peguero, Julio, Dols, Manuel Cobo, Ursol, Grygorii, Kalinka, Ewa, Ledo, Gema Garcia, Martinez, Laia Vilà, Krebs, Matthew, Iams, Wade T, Mueller, Christian, Brignone, Chrystelle, Triebel, Frederic
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
A LAG-3-Specific Agonist Antibody for the Treatment of T Cell-Induced Autoimmune Diseases
Angin, Mathieu, Brignone, Chrystelle, Triebel, Frédéric
Published in The Journal of immunology (1950) (15.02.2020)
Published in The Journal of immunology (1950) (15.02.2020)
Get full text
Journal Article
948 Final results from AIPAC: A phase IIb comparing eftilagimod alpha (a soluble LAG-3 protein) vs. placebo in combination with weekly paclitaxel in HR+ HER2- MBC
Wildiers, Hans, Dirix, Luc, Armstrong, Anne, Cuypere, Eveline De, Dalenc, Florence, Chan, Steven, Marme, Frederik, Schröder, Carolina Pia, Huober, Jens, Vuylsteke, Peter, Jacquin, Jean-Philippe, Brain, Etienne, Kümmel, Sherko, Pápai, Zsuzsanna, Mueller, Christian, Brignone, Chrystelle, Triebel, Frederic
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
790 A phase II study (TACTI-002) of eftilagimod alpha (a soluble LAG-3 protein) with pembrolizumab in PD-L1 unselected patients with metastatic non-small cell lung(NSCLC) or head and neck carcinoma(HNSCC)
Krebs, Matthew, Majem, Margarita, Felip, Enriqueta, Forster, Martin, Doger, Bernard, Clay, Tim, Carcereny, Enric, Peguero, Julio, Horn, Leora, Bajaj, Pawan, Roxburgh, Patricia, Brignone, Chrystelle, Mueller, Christian, Triebel, Frederic
Published in Journal for immunotherapy of cancer (01.11.2020)
Published in Journal for immunotherapy of cancer (01.11.2020)
Get full text
Journal Article
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
Brignone, Chrystelle, Gutierrez, Maya, Mefti, Fawzia, Brain, Etienne, Jarcau, Rosana, Cvitkovic, Frédérique, Bousetta, Nabil, Medioni, Jacques, Gligorov, Joseph, Grygar, Caroline, Marcu, Manon, Triebel, Frédéric
Published in Journal of translational medicine (23.07.2010)
Published in Journal of translational medicine (23.07.2010)
Get full text
Journal Article
MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis
Hemon, Patrice, Jean-Louis, Francette, Ramgolam, Kiran, Brignone, Chrystelle, Viguier, Manuelle, Bachelez, Hervé, Triebel, Frédéric, Charron, Dominique, Aoudjit, Fawzi, Al-Daccak, Reem, Michel, Laurence
Published in The Journal of immunology (1950) (01.05.2011)
Published in The Journal of immunology (1950) (01.05.2011)
Get full text
Journal Article
Alternative Activation of Human Plasmacytoid DCs In Vitro and in Melanoma Lesions: Involvement of LAG-3
Camisaschi, Chiara, De Filippo, Annamaria, Beretta, Valeria, Vergani, Barbara, Villa, Antonello, Vergani, Elisabetta, Santinami, Mario, Cabras, Antonello Domenico, Arienti, Flavio, Triebel, Frédéric, Rodolfo, Monica, Rivoltini, Licia, Castelli, Chiara
Published in Journal of investigative dermatology (01.07.2014)
Published in Journal of investigative dermatology (01.07.2014)
Get full text
Journal Article
A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma
BRIGNONE, Chrystelle, ESCUDIER, Bernard, GRYGAR, Caroline, MARCU, Manon, TRIEBEL, Frédéric
Published in Clinical cancer research (01.10.2009)
Published in Clinical cancer research (01.10.2009)
Get full text
Journal Article
New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016
Adusumilli, Prasad S, Cha, Edward, Cornfeld, Mark, Davis, Thomas, Diab, Adi, Dubensky, Thomas W, Evans, Elizabeth, Grogan, Jane L, Irving, Bryan A, Leidner, Rom S, Olwill, Shane A, Soon-Shiong, Patrick, Triebel, Frederic, Tuck, David, Bot, Adrian, Dansey, Roger D, Drake, Charles G, Freeman, Gordon J, Ibrahim, Ramy, Patel, Salil, Chen, Daniel S
Published in Journal for Immunotherapy of Cancer (20.06.2017)
Published in Journal for Immunotherapy of Cancer (20.06.2017)
Get full text
Journal Article
Book Review